Industry Outlook
The global nanoemulsion market projected to reach US$ 14,760.4 Mn by 2026 from US$ 6,827.5 Mn in 2017, growing at a CAGR of 8.9% during the forecast period from 2018 to 2026. Technically nanoemulsions are thermodynamically stable, isotropic, translucent or transparent, and dispersions of oil & water stabilized with a film linking surfactant molecules with a droplet size of 20 to 500nm. Nanoemulsions are widely used in several applications such as vaccine delivery, DNA encoded drug, antibiotics, cosmetic & topical preparations. The key advantages of nanoemulsions are elimination of inconsistency in absorption, enhancing the absorption rate, assists solubility of lyophilic drug, increases bioavailability, and high thermodynamic stability. The key factors restraining the growth of nanopharmaceutical market are demand for improved characterization, potential toxicity issues, absence of explicit regulatory guidelines, unorganized cost-benefit strategies, and declining interest of a few health care professionals.
"Intravenous route will grow significantly throughout the forecast period due to ongoing expansion in different therapeutic areas"
Emulsions deliver a central oil core, stably dispersed in water, which can act as reservoir for hydrophobic drugs. Emulsion are preferred for topical administration, the small size of nanoemulsions makes them attractive for parenteral delivery. In addition to solubilization of hydrophobic drugs, emulsions can reduce pain or irritation upon injection, improve pharmacokinetics, allow for new forms of administration, and can provide for sustained or targeted release. Nanoemulsion is ideal for parenteral delivery compared to macroemulsion due to higher bioavailability, and longer residence time in the body. Mucosal vaccines manufactured with nanoemulsion assists needle-free immunization by transporting recombinant protein, deactivated organism to a mucosal surface as nanoemulsion leads the protein surface to be adjuvanted, and facilitating uptake by antigen-presenting cells. Thus, intravenous route expected to grow significantly during the forecast period from 2018 to 2026.
"Increasing demand for formulations with high bioavailability and therapeutic efficiency is assisting the growth of nanoemulsion market in Asia Pacific"
Asia Pacific was the fastest growing nanoemulsion market throughout the forecast period from 2018 to 2026 due to key driving factors such as developing pharmaceutical research & development infrastructure, rising awareness related to early disease diagnosis & treatment, and incessant research in the field of nanoemulsion technology. In year 2017, North America dominated the nanoemulsion market and expected to maintain its dominance throughout the forecast period. The key factors responsible for North America’s growth comprises technologically advanced research & development facilities, increasing demand for efficient drug formulations, and key market players are based in this region.
This report further describes the major qualitative assessment factors including key market trends, market drivers & restraints, to assist in better understanding of global nanoemulsion market. Furthermore, the key players analyzed graphically based on their product offering, market strategies and business strength. The report also provides attractive investment proposition based on the extensive geographical research carried out based on PESTEL analysis. Key players profiled in the report include AbbVie Inc., Allergan plc, AstraZeneca plc, Fresenius Kabi AG, Kaken Pharmaceutical Co., Ltd., Covaris, Inc., NanoBio Corporation, Novartis AG, GlaxoSmithKline plc, and Sanofi S.A. among others.
Historical & Forecast Period
This study report represents analysis of each segment from 2022 to 2032 considering 2023 as the base year. Compounded Annual Growth Rate (CAGR) for each of the respective segments estimated for the forecast period of 2024 to 2032.
The current report comprises of quantitative market estimations for each micro market for every geographical region and qualitative market analysis such as micro and macro environment analysis, market trends, competitive intelligence, segment analysis, porters five force model, top winning strategies, top investment markets, emerging trends and technological analysis, case studies, strategic conclusions and recommendations and other key market insights.
Research Methodology
The complete research study was conducted in three phases, namely: secondary research, primary research, and expert panel review. key data point that enables the estimation of Nanoemulsion market are as follows:
Market forecast was performed through proprietary software that analyzes various qualitative and quantitative factors. Growth rate and CAGR were estimated through intensive secondary and primary research. Data triangulation across various data points provides accuracy across various analyzed market segments in the report. Application of both top down and bottom-up approach for validation of market estimation assures logical, methodical and mathematical consistency of the quantitative data.
ATTRIBUTE | DETAILS |
---|---|
Research Period | 2022-2032 |
Base Year | 2023 |
Forecast Period | 2024-2032 |
Historical Year | 2022 |
Unit | USD Million |
Segmentation | |
Route of Administration
| |
Application
| |
Region Segment (2022-2032; US$ Million)
|
Key questions answered in this report